Myriad announces Prequel Prenatal Screening can be performed at 8 weeks

Myriad Genetics (MYGN) announced that the Prequel Prenatal Screen is now available at eight weeks into pregnancy. Enabled by its AMPLIFY technology, Prequel is the first and only prenatal cell-free DNA, cfDNA, screen available at eight-weeks gestational age. “Previously, I would schedule my patients to come in at eight weeks for their first prenatal appointment; then, I would ask them to come back two weeks later to do a Prequel screen. Now that Prequel can be performed at eight weeks, patients have the opportunity to complete all baseline lab work during that initial care visit,” said Dallas Reed, MD, FACMG, FACOG, obstetrician-gynecologist and medical geneticist who serves as the Principal Medical Advisor of Women’s Health for Myriad Genetics. “As a result of this earlier timeframe, providers and their patients can obtain valuable genetic information earlier in the pregnancy, enabling them to make informed decisions based on that information sooner.”